Tag: Q4FY24
Metropolis Healthcare reports 15% growth in core revenue in Q4FY24
The company’s key highlights include a surge in patient volume by 9% and strong B2C revenue growth
Biocon’s biosimilars revenue crosses milestone of US $1 Billion in FY...
The company garnered an overall revenue of Rs 15,621 Crore in FY24, marking a remarkable 35% growth compared to the previous year